Profile | GDS4284 / 218575_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 2476.65 | 86 |
GSM687648 | Patient 402 control | 1956.87 | 83 |
GSM687653 | Patient 403 control | 2199.19 | 85 |
GSM687658 | Patient 404 control | 915.238 | 73 |
GSM687663 | Patient 411 control | 2243.54 | 85 |
GSM687668 | Patient 422 control | 2189.93 | 85 |
GSM687673 | Patient 424 control | 1774.05 | 82 |
GSM687678 | Patient 425 control | 1553.34 | 80 |
GSM687683 | Patient 427 control | 1522.77 | 80 |
GSM687688 | Patient 428 control | 1520.98 | 80 |
GSM687695 | Patient 441 control | 1174.55 | 78 |
GSM687699 | Patient 443 control | 1656.65 | 82 |
GSM687704 | Patient 444 control | 2218.38 | 85 |
GSM687707 | Patient 448 control | 1874 | 83 |
GSM687712 | Patient 449 control | 1853.58 | 83 |
GSM687719 | Patient 450 control | 1141.56 | 76 |
GSM687724 | Patient 451 control | 2122.26 | 85 |
GSM687728 | Patient 452 control | 1463.8 | 80 |
GSM687646 | Patient 401 treated 24h | 1649.92 | 81 |
GSM687649 | Patient 402 treated 24h | 2215.91 | 85 |
GSM687665 | Patient 411 treated 24h | 2399.84 | 86 |
GSM687651 | Patient 402 treated 4 weeks | 1698.59 | 81 |
GSM687667 | Patient 411 treated 4 weeks | 2071.57 | 84 |
GSM687670 | Patient 422 treated 24h | 1949.47 | 83 |
GSM687671 | Patient 422 treated 4 weeks | 2547.65 | 87 |
GSM687654 | Patient 403 treated 24h | 2508.38 | 87 |
GSM687675 | Patient 424 treated 24h | 1839.83 | 83 |
GSM687685 | Patient 427 treated 24h | 1864.94 | 83 |
GSM687656 | Patient 403 treated 4 weeks | 2770.82 | 88 |
GSM687677 | Patient 424 treated 4 weeks | 1961.23 | 83 |
GSM687687 | Patient 427 treated 4 weeks | 1797.1 | 82 |
GSM687692 | Patient 428 treated 4h | 1552.52 | 80 |
GSM687716 | Patient 449 treated 4h | 1865.27 | 83 |
GSM687722 | Patient 450 treated 4h | 1291.85 | 78 |
GSM687680 | Patient 425 treated 24h | 1899.58 | 83 |
GSM687690 | Patient 428 treated 24h | 1336 | 79 |
GSM687700 | Patient 443 treated 24h | 1298.51 | 78 |
GSM687705 | Patient 444 treated 24h | 2058.47 | 84 |
GSM687714 | Patient 449 treated 24h | 1676 | 82 |
GSM687721 | Patient 450 treated 24h | 1635.93 | 82 |
GSM687682 | Patient 425 treated 4 weeks | 1601.07 | 81 |
GSM687694 | Patient 428 treated 4 weeks | 2132.07 | 84 |
GSM687702 | Patient 443 treated 4 weeks | 1706.53 | 82 |
GSM687718 | Patient 449 treated 4 weeks | 1728.81 | 82 |
GSM687723 | Patient 450 treated 4 weeks | 1974.88 | 84 |
GSM687661 | Patient 404 treated 4h | 1129.43 | 76 |
GSM687710 | Patient 448 treated 4h | 2560.94 | 87 |
GSM687726 | Patient 451 treated 4h | 1856.92 | 83 |
GSM687730 | Patient 452 treated 4h | 1461.26 | 81 |
GSM687660 | Patient 404 treated 24h | 564.04 | 66 |
GSM687697 | Patient 441 treated 24h | 1450.9 | 80 |
GSM687709 | Patient 448 treated 24h | 2135.46 | 85 |
GSM687725 | Patient 451 treated 24h | 2256.22 | 86 |
GSM687729 | Patient 452 treated 24h | 1104.66 | 77 |
GSM687727 | Patient 451 treated 4 weeks | 2719.11 | 88 |
GSM687731 | Patient 452 treated 4 weeks | 1875.4 | 83 |